top of page
specialist-neurologist-doctor-taking-notes-laptop-asking-patient-s-symptoms-adjusting-high

Frontiers in Neurology & Neuromuscular Research 2026

Theme : “Integrating Genomics, AI and Neurotechnology in Neurology & Neuromuscular Medicine”

London, UK  |  September 23–24, 2026

Organized by Pulsecon Global – www.pulseconglobal.com

ddvvcdv.jpg

About the Conference

Organized by Pulsecon Global, NeuroFrontiers 2026 serves as a global platform to bridge the gap between research and patient care. The event highlights cutting-edge science in genetics, imaging, neuro-immune interactions, rehabilitation, and digital health. Unlike hybrid or virtual meetings, this congress prioritizes live, interactive learning and networking experiences. London provides the ideal venue to bring together academics, clinicians, industry partners, and policymakers under one roof

Why Attend?

  • Gain insights from global leaders in neurology and neuromuscular research

  • Access the latest breakthroughs in clinical and translational science

  • Network with peers, industry innovators, and policymakers

  • Participate in interactive workshops, live demos, and case discussions

  • Present your work and receive recognition through awards

  • Explore collaboration opportunities with academic and industry partners

Business Coffee Meeting
Abstract Blue Geometric Design

2‑Days Agenda Program

NeuroFrontiers 2026, London, UK
September 23-24, 2026

Day 1

Frontiers in Neurogenetics, AI & Clinical Innovations

08:30 AM – 09:00 AM 

Registration & Welcome Coffee

09:00 AM – 09:20 AM

Opening Ceremony & Welcome Remarks

09:20 AM – 10:00 AM

Keynote 1: “Shaping the Future of Neuromuscular Research: From Genes to Global Health”

10:00 AM – 11:15 AM

Plenary: Neurogenetics and AI in Neurology

  • Track 1: Neurogenetics & Gene Therapies

  • Track 2: AI in Neurodiagnostics & EMG

  • Track 13: Ethical AI & Rare Disease Diagnostics

11:15 AM – 11:30 AM

Coffee Break

11:30 AM – 12:45 PM

Parallel Scientific Sessions

  • Track 3: Spinal Cord Stimulation & Neuromuscular Recovery

  • Track 4: Surgical Frontiers in Peripheral Nerve Injuries

  • Track 7: TMS & Neuromuscular Plasticity

12:45 PM – 13:45 PM

Networking Lunch

13:45 PM – 15:00 PM

​Parallel Scientific Sessions

  • Track 5: Neuroepidemiology & Forecasting Rare Disorders

  • Track 6: Neuro‑Immune Interactions

  • Track 8: AI & Multimodal Imaging for Neuro‑Muscular Diagnosis

15:00 PM – 15:30 PM

Coffee Break

15:30 PM – 16:30 PM

Panel: Equity & Access in Neuromuscular Care

  • Track 9: Global Health & Equity

  • Track 18: Sex, Gender & Hormonal Influences

16:30 PM – 17:00 PM

Poster & Networking Session

17:00 PM – 17:30 PM

​Closing Plenary Day 1: “From Bench to Bedside: Translating Neuro‑Muscular Discoveries”

Day 2

Translational Research, Robotics & Holistic Care

08:30 AM – 09:00 AM 

Morning Coffee & Networking

09:00 AM – 09:40 AM

Keynote 2: “Neuro‑Robotics, AI & The Next Era of Rehabilitation”

09:40 AM – 11:00 AM

Plenary Panel: Innovations in Recovery & Rehabilitation

  • Track 10: Neurodevelopment & Pediatric Neuromuscular Syndromes

  • Track 11: Neurovascular Coupling & Muscle Recovery Post‑Stroke 

  • Track 12: Neuro‑Robotics & Functional Limb Restoration

11:00 AM – 11:15 AM

Coffee Break

11:15 AM – 12:30 PM

Parallel Scientific Sessions

  • Track 14: Omics & Systems Biology in Movement Disorders

  • Track 15: Post‑Viral Neuromuscular Syndromes & Long COVID

  • Track 16: Virtual & Mixed Reality in Neurorehabilitation

12:30 PM – 13:30 PM

Lunch & Networking

13:30 PM – 14:45 PM

Parallel Scientific Sessions

  • Track 17: Drug Repurposing

  • Track 19: Fatigue, Aging & Brain‑Muscle Crosstalk

  • Track 20: Nutrition, Mitochondria & Neuromuscular Optimization

14:45 PM – 15:15 PM

Coffee Break

15:15 PM – 16:15 PM

Plenary: Computational Neuroscience & AI

  • Track 21: Computational Neuroscience

  • Track 22: Parkinson’s Disease

  • Track 23: Neuro‑AI & Large Language Models in Clinical Neurology

16:00 PM – 16:45 PM

Special Symposium

  • Track 24: Brain–Gut–Muscle Axis in Neurological & Neuromuscular Disorders

16:45 PM – 17:15 PM

Awards & Recognition Ceremony

17:15 PM – 17:30 PM

Closing Remarks & Future Outlook

Note: Exact speakers, rooms and chairpersons will be assigned in the final program.

Who Should Attend?

The conference is open to professionals across the healthcare, academic, and industry spectrum, including:

Neurologists, Neurosurgeons & Neuroscientists

Data Scientists, AI Experts, & Biomedical Engineers​

​Neuromuscular Specialists & Rehabilitation Experts

Policy Makers & Global Health Leaders

Geneticists & Molecular Biologists

Pharma, Biotech, and MedTech Industry Professionals

Pediatric & Geriatric Neurology Professionals​

Students, Residents, and Early-Career Investigators​

Abstract Waves

Scientific Sessions

Track 1: Neurogenetics and Gene Therapies Across the Motor Axis

This track focuses on genetic therapies such as CRISPR, viral vectors, and ASOs for SMA, ALS, and dystrophies. It covers clinical trials, newborn screening, ethics, and equitable access

Track 2: Artificial Intelligence in Neurodiagnostics and Electromyography

Explores AI-powered EMG and electrophysiology interpretation, predictive modeling, and clinical integration, addressing accuracy, bias, and clinical validation

Track 3: Spinal Cord Stimulation and Neuromuscular Recovery​​

Covers neuromodulation technologies restoring mobility after injury, rehabilitation protocols, clinical outcomes, and device engineering innovations

​

Track 4: Surgical Frontiers in Peripheral Nerve Injuries

Highlights microsurgery, grafting, bioengineered scaffolds, imaging, and intraoperative advances to optimize nerve repair and recovery

Track 5: Neuroepidemiology and Forecasting Rare Disorders

Focuses on big data, global registries, and analytics to predict disease burden, shape policies, and identify underserved populations

Track 6: Neuro-Immune Interactions in Neuromuscular Disease

Explores autoimmune neuropathies, inflammatory myopathies, biomarkers, and therapeutic immunomodulation strategies

​

Track 7: Transcranial Magnetic Stimulation and Neuromuscular Plasticity

Examines non-invasive brain stimulation in recovery, motor reorganization, ALS, and dystonia, with focus on translational protocols

Track 8: AI and Multimodal Imaging for Integrated Neuro-Muscular Diagnosis

Integrates AI with MRI, PET, CT, ultrasound for precision diagnosis, addressing data validation and clinical integration

​

Track 9: Global Health and Equity in Neuromuscular Care

​

Explores disparities in neuromuscular care access, global policy frameworks, and collaborative approaches for equity

​

Track 10: Neurodevelopment and Pediatric Neuromuscular Syndromes

Addresses early-onset syndromes, pediatric gene therapies, supportive care, and long-term management strategies

​

Track 11: Neurovascular Coupling and Muscle Recovery Post-Stroke

Examines brain-muscle vascular dynamics, imaging biomarkers, and integrated rehabilitation strategies

​

Track 12: Neuro-Robotics and Functional Limb Restoration

Highlights prosthetics, robotics, BMIs, and rehabilitation integration, emphasizing usability and adoption

​

Track 13: Ethical AI and Rare Disease Diagnostics

Covers algorithmic fairness, transparency, patient privacy, and responsible AI in rare disease care

​

Track 14: Omics and Systems Biology in Movement Disorders

Explores genomics, proteomics, metabolomics, systems modeling, and translational applications in movement disorders

Track 15: Post-Viral Neuromuscular Syndromes and Long COVID

Covers neuropathies, fatigue, and neuromuscular syndromes linked to infections, with rehabilitation and care models

Track 16: Virtual Reality and Mixed Reality in Neurorehabilitation

Highlights immersive VR/MR tools for rehabilitation, patient engagement, and cost-effective scalability

​

Track 17: Drug Repurposing in Neurology and Neuromuscular Disease

Focuses on adapting existing drugs for new indications, clinical trial case studies, and translational speed

​

Track 18: Sex, Gender, and Hormonal Influences in Neuro-Muscle Disorders

Examines biological and hormonal influences, gender-specific outcomes, and tailored interventions

​

Track 19: Fatigue, Aging, and Brain-Muscle Crosstalk

Covers neural and mitochondrial changes driving fatigue in aging, prevention, and rehabilitation strategies

​

Track 20: Nutrition, Mitochondria, and Neuromuscular Optimization

Explores nutrition, diet, and metabolic interventions to optimize neuromuscular function and resilience

​

Track 21: Computational Neuroscience​

Highlights computational models, neural simulations, AI algorithms, and their application in neurology research

​

Track 22: Parkinson's Disease

​​

 

Dedicated to Parkinson’s care innovations including biomarkers, DBS, digital monitoring, and patient-centered management

Track 22: Neuro-AI and Large Language Models in Clinical Neurology

​

Examines AI and LLMs for clinical decision support, EHR integration, and research acceleration

​

Track 24: Brain–Gut–Muscle Axis in Neurological and Neuromuscular Disorders

Covers microbiome-brain-muscle interactions, diet influences, and translational therapeutic strategies

​

Scientific Sessions
Researcher

Submit Abstract

Abstracts must be ≤300 words, structured into Background, Methods, Results, and Conclusion. Each submission should include author details and 5–8 keywords. All abstracts are peer-reviewed and notifications of acceptance are issued within 24–48 hours. Accepted abstracts will appear in the official proceedings and be eligible for awards

Key Dates:

Abstract Submission Opens: 15 November 2025​

Early Submission Deadline: 15 February 2026

Final Submission Deadline: 15 May 2026

Notification of Acceptance: After 24hrs Abstract Submission

Presenter Registration Deadline: 15 July 2026

Participation Benefits

All participants of NeuroFrontiers 2026 will gain benefits that go beyond attendance. The congress is designed to ensure knowledge-sharing, professional growth, and recognition. Benefits include

  • Full access to keynotes, sessions, workshops, and the Innovation Forum.

  • Certificate of Participation (with CME/CE credits if applicable)

  • Eligibility for research awards and recognition

  • Opportunities to present work in oral, poster, or e-poster formats

  • High-value networking with peers, industry experts, and global leaders

  • Exclusive exposure to publishing opportunities and professional collaborations

pexels-kerim-isazade-2148708032-31129059.jpg

Venue

About London, UK

 

London, the capital of the United Kingdom, is one of the world’s most dynamic and influential cities — a global hub for business, research, and culture. Renowned for its rich history and modern innovation, London is home to leading universities, research hospitals, and medical institutions, making it an ideal destination for an international conference on neurology and neuromuscular research.Well connected by five international airports, London welcomes visitors from across the globe with ease. The city offers excellent infrastructure for conferences, with world-class venues, diverse accommodation options, and seamless transport through its famous Underground (Tube), buses, and rail network. Delegates can conveniently travel across the city using Oyster or contactless payment cards.In late September, London enjoys mild weather with pleasant temperatures averaging 18–20 °C, perfect for exploring. Attendees can discover iconic landmarks such as the Tower of London, Buckingham Palace, Big Ben, and the River Thames, or enjoy the city’s cultural offerings including museums, galleries, theatres, and historic parks.London is also celebrated for its diversity, offering a wide range of international cuisines and multilingual services, ensuring comfort for delegates from all regions. With its blend of tradition and innovation, the city provides an inspiring environment for meaningful scientific exchange, networking, and collaboration.Hosting the NeuroFrontiers 2026 in London ensures not only a high-impact academic experience but also an unforgettable opportunity to immerse in the vibrant energy of one of the world’s greatest cities.

Person Analyzing Graphs On Screen

Market Analysis

The neurology and neuromuscular space is undergoing rapid transformation, fueled by breakthroughs in genetics, AI, and rehabilitative technology. Here are updated insights into market size and trends:

  • The neuromuscular disease therapeutics market will expand from USD 11.89 billion in 2023 to ~USD 45.62 billion by 2033.

  • The neurology devices market will reach ~USD 21.28 billion by 2030, growing at ~8.90% CAGR.

  • Digital health in neurology is expected to hit USD 130.8 billion by 2030, at ~22.2% CAGR.

  • Gene & nucleic acid therapies for neuromuscular diseases will rise from USD 9.4 billion (2025) to ~USD 23.4 billion by 2035.​

Key drivers include aging populations, growing prevalence of neurodegenerative diseases, precision medicine, AI diagnostics, wearables, and investment flows. Challenges remain in global access, regulatory hurdles, data privacy, and equitable distribution.

 

NeuroFrontiers 2026 positions itself as a strategic platform to align academia, industry, and global health leaders in shaping the future of neurology

pluses.png

​Contact Us

 

PULSECON GLOBAL EVENTS PRIVATE LIMITED

Registered office: Pirhauli, Alinagar , Darbhanga , Bihar, India-847405

Contact No.: +918434830256
Email: frontiersneurology@pulseconglobalevents.com
Phone/whatsapp: +44-3308221359

Quick Links

 

Follow Us

 

  • Facebook
  • Twitter
  • Instagram
  • Youtube

Copyright © 2025 - 2026 PulseconGlobal all rights reserved.

Privacy Policy

Cookies Policy

bottom of page